Tampa, Fla. – Delegates from Tianjin Medical University Cancer Institute and Hospital are spending a few days at Moffitt Cancer Center meeting with leadership to explore the advancement of personalized medicine in China.
Over the past several years, Moffitt and Tianjin have developed a strong collaborative relationship that furthers both of the institutions efforts in cancer education and research. A number of Tianjin’s fellows, post-docs and nurses are meeting with members of Moffitt to share information and learn from each other.
“Both of our institutions have a common vision and culture,” said William S. Dalton, Ph.D., M.D., CEO and center director of Moffitt. “We look forward to a continued partnership with this outstanding and well recognized institution.”
Tianjin is located in northern China and is the sixth largest city of the People's Republic of China. Tianjin Medical University Cancer Institute and Hospital is the birthplace of oncology in China. It has a history of more than a hundred years and has become one of the most famous modernized cancer hospitals worldwide. It is also one of the largest bases for cancer prevention, treatment, training and research in China.
Dr. Hao quote.
About Moffitt Cancer Center
Located in Tampa, Florida, Moffitt Cancer Center is an NCI Comprehensive Cancer Center - a designation that recognizes Moffitt’s excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt currently has 14 affiliates in Florida, one in Georgia and two in Puerto Rico. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country’s leading cancer centers, and is listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer. Moffitt’s sole mission is to contribute to the prevention and cure of cancer.